Dr. Renee Wegrzyn serves as the first director of the Advanced Research Projects Agency for Health (ARPA-H), appointed on October 11, 2022, by President Joseph R. Biden. Previously, Wegrzyn served as a vice president of business development at Ginkgo Bioworks and head of innovation at Concentric by Ginkgo where she focused on applying the tools of synthetic biology to outpace infectious diseases. Wegrzyn comes to ARPA-H with experience working for over a decade at the Defense Advanced Research Projects Agency (DARPA), five of those years as a program manager with a $250 million portfolio, and as a technical advisor to the Intelligence Advanced Research Projects Activity (IARPA). At DARPA, Wegrzyn leveraged the tools of synthetic biology and gene editing to enhance biosecurity, support the domestic bioeconomy, and thwart biothreats. Wegrzyn received the Superior Public Service Medal for her work and contributions at DARPA.
